Clinical Trials Directory

Trials / Terminated

TerminatedNCT00681512

The Effect of Berries on Lung Cancer Tumors

Berry Interventional Trial (BIT) in Resected Non-Small Cell Lung Cancer

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
6 (actual)
Sponsor
University of Louisville · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine how berries affect cancer tumors in patients with non-small cell lung cancer.

Detailed description

In the United States, more people (161,840 per year) die of lung cancers than of prostate cancer, breast cancer and colon cancer combined. Presently, there are over 43 million current smokers and over 47 million ex-smokers living in the US. Due to the lag time between smoking and the development of cancer, there are significant numbers of ex-smokers and current smokers who may develop lung cancer compared to never smokers. Recent studies in animals have shown that berries, given as a dietary supplement, are highly effective against certain types of cancers. In a study involving mice with lung tumors, mice that had consumed a mixture of berries developed fewer tumors and had less tumor growth than mice that did not consume berries. The berries used in this study will consist of blueberries, black raspberries, or a mixture of both.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTberry powderAll subjects (lung cancer survivors and volunteers) will consume 20 grams of berry powder (blueberries, black raspberries, or a mixture of both) per day by mouth for the first 3 days, then 40 grams of berry powder by mouth every day for 4 to 5 weeks. The berry powder is to be mixed in subject's routine intake of milk, yogurt, juice, or water. All subjects will have the option to continue the berry regimen for an extended period. Subjects who choose to do so will not consume any berry powder for one week. After one week, subjects will begin consuming 40 grams of the berry powder every day for an additional 4 to 5 weeks.

Timeline

Start date
2008-04-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2008-05-21
Last updated
2018-02-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00681512. Inclusion in this directory is not an endorsement.